The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A multitranscript blood neuroendocrine tumor molecular signature to identify treatment efficacy and disease progress.
Irvin M. Modlin
Employment or Leadership Position - Wren Laboratories LLC
Consultant or Advisory Role - Wren Laboratories LLC
Ignat Drozdov
No relevant relationships to disclose
Mark S. Kidd
No relevant relationships to disclose